Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells
Blood Science · 2019-08 · 1 (1) · 92-101
DOI: 10.1097/bs9.0000000000000002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Science, 2019-08. Verfasst von Shanshan Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) self-renew or differentiate through division. Cytokines are essential for inducing HSC division, but the optimal cytokine combination to control self-renewal of HSC in vitro remains unclear. In this study, we compared the effects of interleukin-12 (IL-12) and thrombopoietin (TPO) in combination with stem cell factor (SCF) on in vitro self-renewal of HSCs. Single-cell assays were used to overcome the heterogeneity issue of HSCs, and serum-free conditions were newly established to permit reproduction of data. In single-cell cultures, CD150 + CD48 − CD41 − CD34 − c-Kit + Sca-1 + lineage − HSCs divided significantly more slowly in the presence of SCF+IL-12 compared with cells in the presence of SCF+TPO. Serial transplantation of cells from bulk and clonal cultures revealed that TPO was more effective than IL-12 at supporting in vitro self-renewal of short-term (6 months) HSCs, resulting in a biphasic reconstitution wave formation. The control of division rate in HSCs appeared to be crucial for preventing the loss of self-renewal potential from their in vitro culture.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
- Project Division of Advanced Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
- Laboratory of Stem Cell Therapy, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Zitieren
APA
Zhang, S., Morita, M., Wang, Z., Ooehara, J., Zhang, S., Xie, M., Bai, H., Yu, W., Wang, X., Dong, F., Wang, J., Ma, S., Yamazaki, S., & Ema, H. (2019). Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells. Blood Science, 1(1), 92-101. https://doi.org/10.1097/bs9.0000000000000002
Vancouver
Zhang S, Morita M, Wang Z, Ooehara J, Zhang S, Xie M, et al. Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells. Blood Science. 2019;1(1):92-101. doi:10.1097/bs9.0000000000000002
BibTeX
@article{Zhang2019,
author = {Zhang, Shanshan and Morita, Maiko and Wang, Zhao and Ooehara, Jun and Zhang, Sen and Xie, Miner and Bai, Haitao and Yu, Wenying and Wang, Xiaofang and Dong, Fang and Wang, Jinhong and Ma, Shihui and Yamazaki, Satoshi and Ema, Hideo},
title = {Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells},
journal = {Blood Science},
year = {2019},
volume = {1},
number = {1},
pages = {92--101},
doi = {10.1097/bs9.0000000000000002}
}
EUVIMED